Skip to main content

Table 4 Differences between SF12 scores between DM and non-DM participants adjusted for the baseline values

From: Longitudinal assessment of the health-related quality of life among older people with diabetes: results of a nationwide study in New Zealand

SF12-PCS

β (SE)

95% CI

P value

SF12-MCS

β (SE)

95% CI

P value

Baseline

0.66 (0.02)

0.63–0.69

< 0.001

Baseline

0.51 (0.01)

0.48–0.54

< 0.001

time

−0.30 (0.03)

−.035, −.025

< 0.001

time

0.09 (0.03)

0.03–0.14

0.003

group

−2.60 (0.44)

−3.46, −1.74

< 0.001

group

−1.77 (0.44)

− 2.63-0.90

< 0.001